^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    GALEAS™ uPCR: ESR1

    Company:
    Nonacus
    Type:
    Laboratory Developed Test
    Related tests:

    Details

    Evidence
    News
    GALEAS uPCR: ESR1 detects eleven of the most prevalent ESR1 variants known to be associated with endocrine therapy resistance. The assay uses ultrasensitive PCR (uPCR), a Nonacus proprietary technology, to deliver improved sensitivity and specificity over standard qPCR, making it comparable to digital PCR and significantly faster and less expensive than next generation sequencing.
    Cancer:
    Breast Cancer
    Gene:
    ER (Estrogen receptor)
    Method:
    ultrasensitive qPCR (uPCR)